{"schema_version":"secwatch.filing_event.v1","accession":"0001333493-25-000078","form_type":"8-K","ticker":"EHTH","cik":"0001333493","company_name":"eHealth, Inc.","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.003786+00:00","generated_at":"2026-05-18T22:09:44.555682+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"eHealth CEO Fran Soistman extends term to Sept 30, 2025; receives $1M retention award","bullets":["CEO Soistman will stay as CEO until successor appointed or Sept 30, 2025, then serve as Executive Advisor through Dec 31, 2025.","Soistman receives $1M retention cash award (payable Jan 2026) and 2025 performance bonus; no separate annual equity or bonus.","Soistman acknowledges no severance on transition; will continue vesting of existing equity.","Stockholders approved amending 2024 Equity Incentive Plan to add 1.5M shares for future grants.","Directors Hass, Soistman, Tolson re-elected; EY ratified as auditor; say-on-pay approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001333493-25-000078","json":"https://secwatch.observer/filing/0001333493-25-000078.json","markdown":"https://secwatch.observer/filing/0001333493-25-000078.md","text":"https://secwatch.observer/filing/0001333493-25-000078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1333493/000133349325000078/0001333493-25-000078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1333493/000133349325000078/ehth-20250618.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:09:44.555682+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7ef83aa82b","claim":"Fran Soistman changed role as executive advisor at eHealth, Inc..","evidence_excerpt":"Mr. Soistman has agreed to continue serving as chief executive officer and all other roles with its subsidiaries through the earlier of (i) the effective date of the appointment of his successor as chief executive officer or (ii) September 30, 2025 (the “CEO Transition” and such period, the “Additional CEO Period”), and following the CEO Transition, to assume the role of executive advisor until December 31, 2025 to assist with the transition to a new chief executive officer (the “Transition Period”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1333493/000133349325000078/0001333493-25-000078-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"agreed to continue serving as chief executive officer and subsequently assume the role of executive advisor"},{"label":"Role","value":"executive advisor"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}